Xiaoying Lu, Ph.D. - Publications

Affiliations: 
University of Southern California, Los Angeles, CA, United States 
Area:
glutamate receptors, LTP, neurodegeneration, calpain

29 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Li Y, Li X, Sun WK, Cheng C, Chen YH, Zeng K, Chen X, Gu Y, Gao R, Liu R, Lu X. Comparison of liver microRNA transcriptomes of Tibetan and Yorkshire pigs by deep sequencing. Gene. PMID 26656174 DOI: 10.1016/j.gene.2015.12.003  0.364
2015 Liao WQ, Qi YL, Wang L, Dong XM, Xu T, Ding CD, Liu R, Liang WC, Lu LT, Li H, Li WF, Luo GB, Lu XC. Recql5 protects against lipopolysaccharide/D-galactosamine-induced liver injury in mice. World Journal of Gastroenterology : Wjg. 21: 10375-84. PMID 26420964 DOI: 10.3748/wjg.v21.i36.10375  0.362
2012 Bajo M, Madamba SG, Lu X, Sharkey LM, Bartfai T, Siggins GR. Receptor subtype-dependent galanin actions on gamma-aminobutyric acidergic neurotransmission and ethanol responses in the central amygdala. Addiction Biology. 17: 694-705. PMID 21955024 DOI: 10.1111/J.1369-1600.2011.00360.X  0.316
2010 Mitsukawa K, Lu X, Bartfai T. Galanin, galanin receptors, and drug targets. Experientia. Supplementum. 102: 7-23. PMID 21299058 DOI: 10.1007/978-3-0346-0228-0_2  0.349
2010 Lu X, Roberts E, Xia F, Sanchez-Alavez M, Liu T, Baldwin R, Wu S, Chang J, Wasterlain CG, Bartfai T. GalR2-positive allosteric modulator exhibits anticonvulsant effects in animal models. Proceedings of the National Academy of Sciences of the United States of America. 107: 15229-34. PMID 20660766 DOI: 10.1073/Pnas.1008986107  0.341
2009 Mitsukawa K, Lu X, Bartfai T. Bidirectional regulation of stress responses by galanin in mice: Involvement of galanin receptor subtype 1 Neuroscience. 160: 837-846. PMID 19272414 DOI: 10.1016/J.Neuroscience.2009.02.063  0.325
2009 Lu X, Bartfai T. Analyzing the validity of GalR1 and GalR2 antibodies using knockout mice. Naunyn-Schmiedeberg's Archives of Pharmacology. 379: 417-20. PMID 19159918 DOI: 10.1007/S00210-009-0394-Z  0.359
2008 Lu X, Ross B, Sanchez-Alavez M, Zorrilla EP, Bartfai T. Phenotypic analysis of GalR2 knockout mice in anxiety- and depression-related behavioral tests. Neuropeptides. 42: 387-97. PMID 18554714 DOI: 10.1016/J.Npep.2008.04.009  0.314
2007 Lu X, Sharkey L, Bartfai T. The brain galanin receptors: targets for novel antidepressant drugs. Cns & Neurological Disorders Drug Targets. 6: 183-92. PMID 17511615 DOI: 10.2174/187152707780619335  0.365
2007 Conti B, Maier R, Barr AM, Morale MC, Lu X, Sanna PP, Bilbe G, Hoyer D, Bartfai T. Region-specific transcriptional changes following the three antidepressant treatments electro convulsive therapy, sleep deprivation and fluoxetine. Molecular Psychiatry. 12: 167-89. PMID 17033635 DOI: 10.1038/Sj.Mp.4001897  0.313
2006 Barr AM, Kinney JW, Hill MN, Lu X, Biros S, Rebek J, Bartfai T. A novel, systemically active, selective galanin receptor type-3 ligand exhibits antidepressant-like activity in preclinical tests. Neuroscience Letters. 405: 111-5. PMID 16854525 DOI: 10.1016/J.Neulet.2006.06.033  0.378
2006 Shi TJ, Hua XY, Lu X, Malkmus S, Kinney J, Holmberg K, Wirz S, Ceccatelli S, Yaksh T, Bartfai T, Hökfelt T. Sensory neuronal phenotype in galanin receptor 2 knockout mice: focus on dorsal root ganglion neurone development and pain behaviour. The European Journal of Neuroscience. 23: 627-36. PMID 16487144 DOI: 10.1111/J.1460-9568.2006.04593.X  0.312
2005 Wirz SA, Davis CN, Lu X, Zal T, Bartfai T. Homodimerization and internalization of galanin type 1 receptor in living CHO cells. Neuropeptides. 39: 535-46. PMID 16242774 DOI: 10.1016/J.Npep.2005.09.001  0.346
2005 Mazarati A, Lu X. Regulation of limbic status epilepticus by hippocampal galanin type 1 and type 2 receptors. Neuropeptides. 39: 277-80. PMID 15944022 DOI: 10.1016/J.Npep.2004.12.003  0.379
2005 Lundström L, Lu X, Langel U, Bartfai T. Important pharmacophores for binding to galanin receptor 2. Neuropeptides. 39: 169-71. PMID 15944008 DOI: 10.1016/J.Npep.2004.12.029  0.331
2005 Lu X, Lundström L, Bartfai T. Galanin (2-11) binds to GalR3 in transfected cell lines: limitations for pharmacological definition of receptor subtypes. Neuropeptides. 39: 165-7. PMID 15944007 DOI: 10.1016/J.Npep.2004.12.013  0.376
2005 Lu X, Mazarati A, Sanna P, Shinmei S, Bartfai T. Distribution and differential regulation of galanin receptor subtypes in rat brain: effects of seizure activity. Neuropeptides. 39: 147-52. PMID 15944003 DOI: 10.1016/J.Npep.2004.12.011  0.403
2005 Lu X, Lundström L, Langel U, Bartfai T. Galanin receptor ligands. Neuropeptides. 39: 143-6. PMID 15944002 DOI: 10.1016/J.Npep.2004.12.012  0.372
2005 Badie-Mahdavi H, Lu X, Behrens MM, Bartfai T. Role of galanin receptor 1 and galanin receptor 2 activation in synaptic plasticity associated with 3',5'-cyclic AMP response element-binding protein phosphorylation in the dentate gyrus: studies with a galanin receptor 2 agonist and galanin receptor 1 knockout mice. Neuroscience. 133: 591-604. PMID 15885916 DOI: 10.1016/J.Neuroscience.2005.02.042  0.364
2005 Jourdi H, Lu X, Yanagihara T, Lauterborn JC, Bi X, Gall CM, Baudry M. Prolonged positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors induces calpain-mediated PSD-95/Dlg/ZO-1 protein degradation and AMPA receptor down-regulation in cultured hippocampal slices. The Journal of Pharmacology and Experimental Therapeutics. 314: 16-26. PMID 15784649 DOI: 10.1124/Jpet.105.083873  0.543
2005 Lu X, Barr AM, Kinney JW, Sanna P, Conti B, Behrens MM, Bartfai T. A role for galanin in antidepressant actions with a focus on the dorsal raphe nucleus. Proceedings of the National Academy of Sciences of the United States of America. 102: 874-9. PMID 15647369 DOI: 10.1073/Pnas.0408891102  0.337
2005 Lu X, Barr AM, Bartfai T. Galanin receptors as novel drug targets for the treatment of depression and anxiety Drug Development Research. 65: 227-236. DOI: 10.1002/Ddr.20026  0.382
2004 Ceide SC, Trembleau L, Haberhauer G, Somogyi L, Lu X, Bartfai T, Rebek J. Synthesis of galmic: a nonpeptide galanin receptor agonist. Proceedings of the National Academy of Sciences of the United States of America. 101: 16727-32. PMID 15557002 DOI: 10.1073/Pnas.0407543101  0.352
2004 Bartfai T, Lu X, Badie-Mahdavi H, Barr AM, Mazarati A, Hua XY, Yaksh T, Haberhauer G, Ceide SC, Trembleau L, Somogyi L, Kröck L, Rebek J. Galmic, a nonpeptide galanin receptor agonist, affects behaviors in seizure, pain, and forced-swim tests. Proceedings of the National Academy of Sciences of the United States of America. 101: 10470-5. PMID 15240875 DOI: 10.1073/Pnas.0403802101  0.369
2004 Mazarati A, Lu X, Kilk K, Langel U, Wasterlain C, Bartfai T. Galanin type 2 receptors regulate neuronal survival, susceptibility to seizures and seizure-induced neurogenesis in the dentate gyrus. The European Journal of Neuroscience. 19: 3235-44. PMID 15217380 DOI: 10.1111/J.0953-816X.2004.03449.X  0.316
2001 Rong Y, Lu X, Bernard A, Khrestchatisky M, Baudry M. Tyrosine phosphorylation of ionotropic glutamate receptors by Fyn or Src differentially modulates their susceptibility to calpain and enhances their binding to spectrin and PSD-95. Journal of Neurochemistry. 79: 382-90. PMID 11677266 DOI: 10.1046/J.1471-4159.2001.00565.X  0.518
2001 Lu X, Wyszynski M, Sheng M, Baudry M. Proteolysis of glutamate receptor-interacting protein by calpain in rat brain: implications for synaptic plasticity. Journal of Neurochemistry. 77: 1553-60. PMID 11413238 DOI: 10.1046/J.1471-4159.2001.00359.X  0.518
2000 Lu X, Rong Y, Baudry M. Calpain-mediated degradation of PSD-95 in developing and adult rat brain. Neuroscience Letters. 286: 149-53. PMID 10825658 DOI: 10.1016/S0304-3940(00)01101-0  0.487
2000 Lu X, Rong Y, Bi R, Baudry M. Calpain-mediated truncation of rat brain AMPA receptors increases their Triton X-100 solubility. Brain Research. 863: 143-50. PMID 10773202 DOI: 10.1016/S0006-8993(00)02112-0  0.526
Show low-probability matches.